Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
MARCH 24, 2023
Market dynamics of authorized generics in Medicaid from 2014 to 2020. Insulin products and patents in the USA in 2004, 2014, and 2020: a cross-sectional study. Assessment of FDA-Approved Drugs Not Recommended for Use or Reimbursement in Other Countries, 2017-2020. JAMA Intern Med. 2023 Feb 13:e226787. Epub ahead of print. 2023 Feb 23.
Let's personalize your content